ALS2 (Alsin) Protein

ALS2 (Alsin) Protein

<div class="infobox infobox-protein">
<div class="infobox-header">ALS2 (Alsin) Protein</div>
<table class="infobox-content">
<tr><th colspan="2" class="section-head">Basic Information</th></tr>
<tr><td class="label">Protein Name</td><td class="value">Alsin</td></tr>
<tr><td class="label">Gene Symbol</td><td class="value">ALS2</td></tr>
<tr><td class="label">UniProt ID</td><td class="value">[Q9UPN3](https://www.uniprot.org/uniprot/Q9UPN3)</td></tr>
<tr><td class="label">PDB Structures</td><td class="value">No crystal structure available</td></tr>
<tr><td class="label">Molecular Weight</td><td class="value">184 kDa</td></tr>
<tr><td class="label">Amino Acids</td><td class="value">1,657</td></tr>
<tr><td class="label">Subcellular Localization</td><td class="value">Cytoplasm, Early Endosomes, Late Endosomes</td></tr>
<tr><td class="label">Protein Family</td><td class="value">RCC1 (Regulator of Chromosome Condensation 1) superfamily, GEFs for small GTPases</td></tr>
<tr><td class="label">Tissue Expression</td><td class="value">Highest in motor neurons, brain cortex, hippocampus</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/frontotemporal-dementia" style="color:#ef9a9a">Frontotemporal Dementia</a>, <a href="/wiki/ftd" style="color:#ef9a9a">Ftd</a></td>
</tr>
<tr>
<td class="label">KG Connections</t

ALS2 (Alsin) Protein

<div class="infobox infobox-protein">
<div class="infobox-header">ALS2 (Alsin) Protein</div>
<table class="infobox-content">
<tr><th colspan="2" class="section-head">Basic Information</th></tr>
<tr><td class="label">Protein Name</td><td class="value">Alsin</td></tr>
<tr><td class="label">Gene Symbol</td><td class="value">ALS2</td></tr>
<tr><td class="label">UniProt ID</td><td class="value">[Q9UPN3](https://www.uniprot.org/uniprot/Q9UPN3)</td></tr>
<tr><td class="label">PDB Structures</td><td class="value">No crystal structure available</td></tr>
<tr><td class="label">Molecular Weight</td><td class="value">184 kDa</td></tr>
<tr><td class="label">Amino Acids</td><td class="value">1,657</td></tr>
<tr><td class="label">Subcellular Localization</td><td class="value">Cytoplasm, Early Endosomes, Late Endosomes</td></tr>
<tr><td class="label">Protein Family</td><td class="value">RCC1 (Regulator of Chromosome Condensation 1) superfamily, GEFs for small GTPases</td></tr>
<tr><td class="label">Tissue Expression</td><td class="value">Highest in motor neurons, brain cortex, hippocampus</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/frontotemporal-dementia" style="color:#ef9a9a">Frontotemporal Dementia</a>, <a href="/wiki/ftd" style="color:#ef9a9a">Ftd</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">105 edges</a></td>
</tr>
</table>
</div>

Overview

Alsin is a large 184 kDa protein encoded by the [ALS2 gene](/genes/als2) that functions as a guanine nucleotide exchange factor (GEF) for small GTPases, primarily Rab5 and Rac1[@hadano2001][@yang2001]. It is predominantly expressed in motor [neurons](/entities/neurons) of the brain and spinal cord, where it plays critical roles in endosomal trafficking, axonal outgrowth, mitochondrial dynamics, and autophagy. Loss-of-function mutations in ALS2 cause a spectrum of autosomal recessive juvenile-onset motor neuron diseases, including juvenile amyotrophic lateral sclerosis (ALS2), primary lateral sclerosis (PLS), and infantile-onset ascending hereditary spastic paralysis (IAHSP)[@devon1993][@mitsumoto2014].

The discovery of ALS2 as a cause of juvenile motor neuron disease highlighted the importance of endosomal trafficking and axonal homeostasis in maintaining motor neuron health. Unlike adult-onset ALS which is typically sporadic or autosomal dominant, ALS2 represents a distinct entity with earlier onset, slower progression, and recessive inheritance.

Structure

Alsin possesses a modular architecture with multiple functional domains:

N-Terminal Region

• MIR (MIP/Sec14-like) domain: Functions as a lipid-binding module that may regulate membrane association
• DExD/H helicase domain: Putative RNA/DNA helicase activity of unknown function
• VPS9 domain: The critical GEF domain that catalyzes GDP/GTP exchange on Rab5

Central Region

• Multiple PH (Pleckstrin Homology) domains: Potential roles in phosphoinositide binding and membrane localization
• C2 domains: Calcium-dependent lipid binding modules that may regulate membrane interactions

C-Terminal Region

• RCC1-like domain: The main GEF catalytic domain for Rab5 and Rac1 activation
• Proline-rich region: Potential SH3 domain binding sites for protein-protein interactions

Normal Physiological Function

Endosomal Trafficking Regulation

Alsin functions as a master regulator of endosomal dynamics through its GEF activity toward Rab5 and Rab11[@topp2012][@otomo2011][@kunita2004]:

• Rab5 activation: Alsins VPS9 domain catalyzes GDP/GTP exchange on Rab5, converting it from its inactive GDP-bound form to the active GTP-bound form
• Early endosome formation: Active Rab5-GTP recruits effectors that mediate homotypic fusion of early endosomes, a critical step in endocytic trafficking
• Endosomal maturation: ALS2 regulates the transition from early to late endosomes through Rab5-dependent processes
• Rab11 coordination: ALS2 also activates Rab11, which regulates recycling endosome trafficking back to the plasma membrane

Axonal Outgrowth and Neurite Development

ALS2 plays a essential role in neuronal process extension[@ghandour2021][@kim2017]:

• Growth cone dynamics: Rac1 activation by ALS2 regulates actin polymerization in growth cones, enabling axon pathfinding
• Axonal transport: Proper endosomal trafficking is essential for delivery of cargoes to developing axons
• Synapse formation: Endosomal trafficking contributes to membrane protein delivery to nascent synapses
• Neuronal polarity: ALS2-mediated endosomal trafficking helps establish and maintain axonal identity

Mitochondrial Dynamics

ALS2 regulates mitochondrial function through multiple mechanisms[@gautam2019][@lo2018]:

• Mitochondrial trafficking: ALS2 influences mitochondrial transport along axons through regulation of Miro1 and Milton proteins
• Mitochondrial fission/fusion: The Rac1 pathway intersects with mitochondrial dynamics regulators
• Mitochondrial quality control: ALS2-deficient neurons show impaired mitophagy and accumulation of dysfunctional mitochondria
• Energy metabolism: Endosomal dysfunction may impair mitochondrial function through disrupted lipid trafficking

Autophagy Regulation

ALS2 intersects with the autophagy pathway through multiple mechanisms[@jacoupy2019][@kanekura2022]:

• Autophagosome formation: Endosomal membranes contribute to autophagosome biogenesis
• Endosomal-lysosomal fusion: ALS2 regulates late endosome function required for autophagic cargo delivery to lysosomes
• Selective autophagy: The protein may participate in aggrephagy (selective autophagy of protein aggregates)
• Lysosomal function: ALS2 deficiency leads to impaired lysosomal degradation capacity

Role in Neurodegenerative Diseases

ALS2-Related Motor Neuron Disease

Recessive mutations in the ALS2 gene cause a spectrum of juvenile-onset motor neuron disorders[@hadano2001][@yang2001][@mitsumoto2014][@bali2021]:

Clinical Phenotypes

• Onset: Typically between ages 2-10 years
• Features: Progressive spasticity, weakness, and atrophy of limb muscles
• Progression: Slow but leads to significant disability over decades
• Bulbar involvement: Dysarthria, dysphagia in later stages

• Onset: Childhood to adolescence
• Features: Predominant upper motor neuron signs (spasticity, hyperreflexia)
• Progression: Very slow, often maintaining ambulation into adulthood
• Cognitive function: Typically preserved

• Onset: First year of life
• Features: Ascending spasticity beginning in lower extremities
• Rapid progression to severe disability

Genetic Mechanism

• Recessive inheritance: Both alleles must be mutated for disease expression
• Mutation types: Missense, nonsense, splice-site, and deletion mutations identified
• Loss of function: Most pathogenic mutations result in reduced or absent alsin protein
• Haploinsufficiency: Partial loss may cause milder phenotypes (carrier effect unclear)

Pathophysiological Mechanisms

Endosomal Trafficking Defects

Loss of ALS2 function disrupts endosomal dynamics throughout the neuron[@kane2022][@kim2017]:

• Early endosome accumulation: Impaired Rab5 function leads to enlarged, dysfunctional early endosomes
• Altered cargo trafficking: Neurotrophic factor receptors and synaptic proteins fail to reach their proper destinations
• Axonal transport deficits: Endosomal cargoes accumulate in axonal swellings
• Protein aggregate accumulation: Impaired trafficking contributes to aggresome formation

Mitochondrial Dysfunction

ALS2 deficiency leads to mitochondrial pathology[@gautam2019][@lo2018]:

• Reduced mitochondrial fission: Impaired Rac1 signaling disrupts DRP1-mediated fission
• Altered mitochondrial trafficking: Defects in Miro1-dependent transport along microtubules
• Accumulation of damaged mitochondria: Impaired mitophagy leads to toxic accumulation
• Energy failure: Combined defects cause ATP depletion in motor neurons

Autophagy Impairment

Loss of ALS2 disrupts autophagic flux[@jacoupy2019][@kanekura2022]:

• Block at endosomal stage: Failure to deliver autophagic cargoes to lysosomes
• Accumulation of lipofuscin: Undegraded material accumulates in neurons
• Aggregate formation: Impaired clearance leads to protein aggregate accumulation
• Activation of ER stress: The Unfolded Protein Response is chronically activated

Synaptic Dysfunction

ALS2 deficiency affects synaptic function[@ghandour2021]:

• Impaired postsynaptic plasticity: Rac1/Pak1 pathway disruption affects dendritic spine morphology
• Reduced synaptic vesicle recycling: Endosomal trafficking defects impair neurotransmitter release
• NMJ denervation: Progressive loss of neuromuscular junction innervation

Overlap with Other Neurodegenerative Diseases

Parkinson's Disease

Although primarily a motor neuron disease, ALS2 has been implicated in [Parkinson's disease](/diseases/parkinsons-disease)[@abou2015]:

• Dopaminergic neuron vulnerability: ALS2 expression in substantia nigra suggests potential role
• Endosomal dysfunction: Shared pathway with PD-linked genes (LRRK2, GBA)
• Genetic overlap: Rare ALS2 variants may modify PD risk

Amyotrophic Lateral Sclerosis

ALS2 shares features with adult-onset [ALS](/diseases/amyotrophic-lateral-sclerosis):

• Motor neuron degeneration: Both involve selective motor neuron loss
• Endosomal trafficking: Common pathway affected by multiple ALS genes
• Protein aggregation: Impaired autophagy contributes to aggregate formation
• Mitochondrial dysfunction: Shared mechanism with SOD1, TDP-43, FUS mutations

Animal Models

Mouse Models

Mouse models have provided key insights into ALS2 function[@martindale2006][@yamanaka2006]:

• Als2 knockout mice: Show subtle motor phenotypes with age
• Motor neuron degeneration: Selective loss in aged knockouts
• Endosomal abnormalities: Accumulation of enlarged endosomes
• Mitochondrial defects: Altered morphology and function

Cross-Disease Interactions

Studies in animal models reveal important interactions[@yamanaka2006]:

• ALS2 and SOD1: Wild-type ALS2 overexpression delays SOD1 mutant-induced motor neuron degeneration
• Compensatory mechanisms: Partial ALS2 loss may be compensated by other Rab5 GEFs
• Therapeutic potential: Restoring endosomal function may benefit multiple motor neuron diseases

Therapeutic Approaches

Gene Therapy Strategies

Multiple approaches to restore ALS2 function are under investigation[@hemel2022]:

• AAV delivery: Adeno-associated virus vectors carrying ALS2 transgenes
• Motor neuron targeting: Optimizing delivery to spinal cord motor neurons
• Conditional expression: Regulated expression to prevent overexpression toxicity
• Variant-specific approaches: Customized for different mutation types

Small Molecule Activators

Pharmacological approaches to enhance endosomal function[@zhao2021]:

• Rab5 activators: Small molecules that enhance Rab5-GTP loading
• Autophagy inducers: Compounds that boost autophagic flux
• Mitochondrial protectants: Agents to preserve mitochondrial function
• Neuroprotective compounds: Broad-spectrum neuroprotective strategies

Symptomatic Management

Current clinical management includes:

• Physical therapy: Maintain range of motion and prevent contractures
• Spasticity management: Baclofen, tizanidine, or botulinum toxin injections
• Respiratory support: Non-invasive ventilation as disease progresses
• Nutritional support: PEG tube feeding when dysphagia develops

Key Publications

Cross-References

• [ALS2 Gene](/genes/als2) — Gene encoding alsin
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Primary disease
• [Parkinson's Disease](/diseases/parkinsons-disease) — Related neurodegenerative disease
• [Primary Lateral Sclerosis](/diseases/primary-lateral-sclerosis) — Related clinical phenotype
• [Motor Neurons](/entities/motor-neurons) — Affected cell type
• [Rab5 Protein](/proteins/rab5-protein) — GEF substrate
• [Rac1 Protein](/proteins/rac1-protein) — GEF substrate
• [Endosomal Trafficking](/mechanisms/endosomal-trafficking) — Pathway
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics) — Pathway
• [Autophagy Mechanisms](/mechanisms/autophagy-mechanisms) — Pathway

See Also

• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Motor Neuron Diseases](/diseases/motor-neuron-diseases)
• [Protein Aggregation](/mechanisms/protein-aggregation-mechanisms)
• [Endocytic Pathway](/mechanisms/endocytic-pathway)

External Links

• [UniProt Q9UPN3](https://www.uniprot.org/uniprot/Q9UPN3)
• [OMIM: 607352](https://www.omim.org/entry/607352)
• [GeneReviews: ALS2](https://www.ncbi.nlm.nih.gov/books/NBK1116/)
• [PubMed ALS2](https://pubmed.ncbi.nlm.nih.gov/?term=ALS2+alsin+motor+neuron)

Pathway Diagram

Key molecular relationships involving als2 from the SciDEX knowledge graph:

Pathway Diagram

The following diagram shows the key molecular relationships involving ALS2 (Alsin) Protein discovered through SciDEX knowledge graph analysis: